Results will be good. Everyone and everything will, as a result, want to move ahead fast.
But they dont have enough money to pay for accelerating the USA adult trial, nor the cost of consultants handling TGA, CE and FDA approvals for both Resapp and the sleep apnoea products.
Moreover they need to put on staff to handle the incoming customers and set up systems
Everything would slow down for 6 months until, post FDA when commercial sales began to provide funds.
Some great offer has been made which was too good to resist.
Fox
- Forums
- ASX - By Stock
- RAP
- Ann: Trading Halt
Ann: Trading Halt, page-52
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 175 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)